Interlude vs Inner Balance: Two Vaginal Creams, Two Completely Different Jobs

Interlude vs Inner Balance is mainly a local-versus-systemic decision. Interlude is better suited to vaginal dryness, painful sex, urinary urgency, and recurrent UTIs, with an FDA-approved generic estradiol option available. Its current generic-cream checkout is $84 upfront. Inner Balance’s Oestra is a compounded systemic estradiol-plus-progesterone program costing $1,791 in year one.

Who is Interlude best for, and who should choose Inner Balance?

Interlude is likely your fit if: your main symptoms are vaginal dryness, painful sex, itching, burning, recurrent UTIs, or urinary urgency · you want a local treatment path · you want an FDA-approved generic option whose strength is published · you are paying cash and want the lower first-year cost.

Inner Balance may be your fit if: you have whole-body symptoms such as hot flashes, night sweats, poor sleep, mood changes, or brain fog · you want estradiol and progesterone in one vaginally applied compounded product · you accept cash-pay pricing · and you are comfortable verifying the exact formula, pharmacy, and monitoring plan before paying.

Neither one, on its own, if: you want FDA-approved whole-body hormone therapy · you have both local and systemic symptoms and want one clinician to coordinate both · you have bleeding after menopause · you need insurance-billed care · or you need an examination or diagnostic workup before anyone writes a prescription.

How do Interlude and Inner Balance compare at a glance?

Difference	Interlude	Inner Balance Oestra
Main treatment job	Local vaginal and urinary care	Systemic, whole-body hormone care
Typical symptom lane	Dryness, painful sex, urgency, recurrent UTIs, GSM	Hot flashes, night sweats, sleep, mood, brain fog, plus vaginal symptoms
Intended exposure	Low-dose local treatment with minimal systemic absorption	Provider-designed systemic absorption
Final-product FDA status	Two FDA-approved generics and separate compounded options	Compounded; not FDA-approved
Progesterone included	No in the local products compared here	Yes, but the currently published dose descriptions conflict
Published starting policy by age	Interlude says there is no age limit	Inner Balance says its cutoff to start is age 59; confirm how it treats someone who is exactly 59
Initial charge	$84 for generic cream: $45 consult + $39 first tube	$199
First 90 days	$84–$143, depending on refill timing	$597
Modeled first year	$202–$379 for shipped generic cream, depending on selected 2–4 month cadence	$1,791
Insurance billing	No	No
HSA/FSA	Interlude says eligible	Inner Balance says eligible, but its pages conflict on refund eligibility for HSA/FSA purchases
Our relationship	We earn nothing	Paid partner

How the price models work: Interlude’s live generic-cream checkout shows $84 due today. With the current $39 introductory product price, the consultation component calculates to $45. Its product page displays a $59 regular price and refill frequencies from two to four months, plus an as-needed option. Inner Balance publishes $199 a month for six months and $99.50 a month afterward. The calculations and assumptions appear in full below. (Interlude generic cream; Interlude checkout; Inner Balance Oestra)

Here’s the part that trips almost everybody up.

Both products are creams. Both go in the same place. Both say “estradiol.” So when you see $39 on one tab and $199 a month on the other, the obvious question is: what on earth is the extra $160 buying?

The answer is a different job entirely. Interlude’s low-dose vaginal products are designed for vaginal and urinary tissue, not hot flashes. Inner Balance markets Oestra as a systemically absorbed estradiol-plus-progesterone treatment for symptoms throughout the body. And if you want FDA-approved whole-body hormone therapy, the honest answer is neither.

Is the right provider the same for every woman?

No. Your symptom pattern, uterus status, age, preferred medication route, medical history, insurance situation, state, and willingness to use a compounded drug can all change the answer. That is why a general comparison can narrow the lane but cannot choose a prescription for you.

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Quick note on who’s who. “Interlude” here means the vaginal and urinary telehealth service at getinterlude.com, operated by GML Health, Inc. “Inner Balance” means the menopause company at innerbalance.com that sells Oestra.

What’s the bottom line on Interlude vs Inner Balance?

Interlude is the better buy when your main symptoms are vaginal or urinary. Inner Balance is the option to consider when your symptoms are whole-body and you knowingly prefer a compounded estradiol-plus-progesterone cream. If you want FDA-approved whole-body hormone therapy, neither one is your answer.

That last row surprises people, so let’s be direct about it.

Interlude’s FDA-approved generic cream and inserts are low-dose local treatments. They are not designed to deliver the systemic hormone levels used to treat hot flashes. Inner Balance’s Oestra is designed for systemic effects, but the finished product is compounded and has not gone through FDA premarket review as an approved drug. The FDA says compounded “bioidentical” hormone products are not FDA-approved and that it does not have evidence they are safer or more effective than FDA-approved hormone therapy. (FDA: Menopause)

So there is no version of this two-company comparison where you get both “FDA-approved final product” and “whole-body Oestra-style treatment.” If that combination is your priority, compare providers that prescribe standard FDA-approved patches, gels, sprays, pills, or approved combination products through The HRT Index’s online HRT provider comparison.

What you are actually looking for	Start here
Vaginal dryness or painful sex on its own	Interlude
Recurrent UTIs or urinary urgency associated with GSM	Interlude
Lowest verified first-year cash commitment	Interlude
Whole-body symptoms and compounded medication is acceptable	Consider Inner Balance
One combined estradiol-plus-progesterone product	Consider Inner Balance
FDA-approved whole-body hormone therapy	Neither
Insurance-billed menopause care	Neither
Both local and whole-body symptoms	One clinician who can evaluate and coordinate both

If your symptoms are vaginal and urinary only, Interlude is the cleaner lane. See Interlude’s current generic cream price — we earn nothing from that link.

Are Interlude and Inner Balance the same kind of medicine?

No. Both are applied vaginally, but the route does not tell you the treatment scope. Interlude’s low-dose vaginal estrogen is intended for local GSM effects with very little entering circulation. Inner Balance markets Oestra for systemic absorption and whole-body effects. Same route, different job.

Where a medicine goes in does not tell you what it is meant to do. A vaginally applied product can be local or systemic depending on the formulation and dose. The applicator can look familiar while the clinical job is completely different.

The Menopause Society separates hormone therapy into two broad categories: systemic therapy reaches blood levels high enough to affect widespread symptoms such as hot flashes, while low-dose vaginal estrogen is used for GSM and sends very little estrogen into circulation. (The Menopause Society: Hormone Therapy)

Inner Balance makes the same distinction on its own education pages. It describes low-dose vaginal estrogen as the route for vaginal or urinary symptoms alone, while describing Oestra as a vaginal cream intended for systemic effects. That is not a gotcha. It is the most useful piece of category clarity on the provider’s site.

We want to be fair here, because this deserves credit rather than a trap. Inner Balance could have blurred the difference and let every vaginal symptom searcher assume Oestra was automatically the next step. Instead, its own education distinguishes low-dose local estrogen from systemic Oestra. We just do not think that distinction should stay buried while the broad symptom marketing sits above it.

Same word, different meaning

Phrase	What it actually tells you
Vaginal cream	Where the product is applied; not whether the intended effect is local or systemic
Vaginal estrogen	Often means low-dose local treatment for GSM, but the exact product and dose still control
Systemic hormone therapy	Hormone exposure intended to affect symptoms throughout the body, including vasomotor symptoms
Bioidentical	A molecular-description term; not an FDA-approval category
Compounded	Prepared for a prescription outside the standard FDA drug-approval process; the finished preparation is not FDA-approved
FDA-approved ingredient	Does not transfer FDA approval to a compounded combination, dose, base, or delivery system
GSM	Genitourinary syndrome of menopause: vaginal, vulvar, sexual, and urinary changes associated with low estrogen

One more that matters: a telehealth company is never “FDA-approved.” Specific drug products are.

Which symptoms does each one actually treat?

Interlude’s terms limit its core hormone service to vaginal atrophy, GSM, and related vaginal or urinary conditions. Inner Balance markets Oestra for systemic symptoms including hot flashes, sleep, mood, and brain fog, as well as vaginal symptoms. If hot flashes are the problem, Interlude’s local lane is the wrong lane.

Interlude’s Terms of Service say its affiliated medical group provides care for vaginal atrophy and genitourinary symptoms of menopause and related conditions, not general medical, gynecologic, or urologic care. Its public site centers vaginal dryness, painful sex, frequent UTIs, urgency, and vaginal atrophy. (Interlude Terms of Service; Interlude)

Here is the symptom map, with the checkmarks labeled honestly:

Your main concern	Interlude	Inner Balance Oestra
Vaginal dryness	Core focus	Provider markets Oestra for it
Painful sex associated with GSM	Core focus	Provider markets Oestra for it
Vaginal itching or burning associated with GSM	Core focus	Provider markets Oestra for it
Recurrent UTIs associated with menopause	Core focus	Not a central stated focus
Urinary urgency	Core focus	Not a central stated focus
Hot flashes	Not the purpose of its low-dose local products	Provider markets Oestra for it
Night sweats	Not the purpose of its low-dose local products	Provider markets Oestra for it
Sleep disruption associated with menopause	Not a systemic HRT program	Provider markets Oestra for it
Brain fog	Not a systemic HRT program	Provider markets Oestra for it
Mood changes	Not a systemic HRT program	Provider markets Oestra for it
Mixed local and whole-body symptoms	May cover the local side only	May cover a systemic side; local symptoms may still need separate evaluation

What the table means: “Core focus” and “provider markets” describe service scope. They do not promise that a medication will work for you or establish an FDA-approved indication for a compounded product.

The clinical category matches the service split. The Menopause Society says systemic hormone therapy is used for widespread symptoms such as hot flashes, while low-dose vaginal estrogen is used for GSM. Some women receiving systemic therapy still need local vaginal treatment for persistent GSM. (The Menopause Society: Hormone Therapy)

Not sure which symptom lane you are in? Match your situation in The HRT Index’s Find My HRT Path tool. It is free, does not require a provider purchase, and flags when online care is not the right first step.

Is either Interlude or Inner Balance FDA-approved?

Interlude offers two FDA-approved generic drug products and separate compounded products. Inner Balance’s Oestra is compounded and is not FDA-approved. The honest comparison is product by product—not “the approved company” versus “the compounded company.”

What does Interlude currently offer?

Interlude product	Final-product status	Published strength	Published quantity	Current introductory price
Estradiol vaginal cream	FDA-approved generic	0.01%; 0.1 mg estradiol per gram	42.5 g	$39, then the page shows $59 undiscounted
Estradiol vaginal inserts	FDA-approved generic	10 mcg per insert	18 inserts; about two months	$109, then the page shows $129 undiscounted
Soothing Estradiol Cream	Compounded	Estradiol 0.003%, hyaluronic acid 0.5%, aloe 0.5%, vitamin E 1%	30 g; about two to three months	$49, then $69 undiscounted
DHEA Vaginal Cream	Compounded	DHEA 2%; 5 mg per 0.25 g pump	30 g; about two months	$49, then $69 undiscounted
Hyaluronic+ Cream	Nonhormonal	No estrogen or progesterone	Confirm on product page	$39 on the current shop

Source: Interlude generic cream, generic inserts, Soothing Estradiol Cream, DHEA Vaginal Cream, and the current DailyMed estradiol cream and 10 mcg insert labels. Prices rechecked August 18, 2026.

The insert price matters because older comparisons still show $89. The current product page shows $109 introductory and $129 undiscounted. That is the live number as of this verification.

The per-gram comparison most pages never calculate

At the current introductory prices:

• Interlude’s FDA-approved generic estradiol cream: $39 ÷ 42.5 g = about $0.92 per gram.
• Its compounded Soothing Estradiol Cream: $49 ÷ 30 g = about $1.63 per gram.

At the displayed undiscounted prices:

• FDA-approved generic: $59 ÷ 42.5 g = about $1.39 per gram.
• Compounded Soothing cream: $69 ÷ 30 g = $2.30 per gram.

That does not prove one formula is clinically better. It tells you the compounded option is not the cheap option. It has a different base and ingredients, so the correct question is not “Why would anyone pay more?” It is “Which formulation is being prescribed, and why does that formulation fit me?”

Interlude names GoGoMeds, Honeybee Health, and Blend among its commercial-medication pharmacy partners and Curexa as its custom-compounding partner. The pharmacy name is a useful clue, but the dispensed label, manufacturer, NDC, and product name are the final verification—not a logo on a shipping box. (Interlude Contact)

Its compounded DHEA cream is also not the same finished product as FDA-approved Intrarosa, a prasterone vaginal insert. “DHEA” is not enough to establish product equivalence.

What does compounded mean for Oestra?

Oestra is a compounded prescription preparation containing estradiol and micronized progesterone. The final Oestra cream has not gone through FDA approval for its exact combination, dose, base, route, effectiveness, quality, or labeling. FDA-approved estradiol and progesterone products exist, but approved ingredients do not transfer approval to a compounded mixture. (FDA: Compounding and menopause)

There is a real reason someone might still consider it: Inner Balance packages estradiol and progesterone into one vaginally applied prescription product. A woman who specifically wants that one-product routine will not find an FDA-approved estradiol-plus-progesterone vaginal cream. That convenience is Oestra’s honest commercial argument. It is not evidence that Oestra is safer, more effective, better absorbed, or equivalent to an FDA-approved systemic regimen.

The FDA recommends FDA-approved hormone therapies and says it does not have evidence that compounded “bioidentical” products are safer or more effective than approved hormone therapy. The Menopause Society likewise says FDA-approved “bioidentical” options already exist and warns that custom-compounded products may not contain predictable hormone amounts. (FDA; The Menopause Society)

Where does our paid partner lose?

Inner Balance pays us. Interlude does not. And for what is probably the largest single group of women reading this page—women whose symptoms are vaginal or urinary only—Inner Balance is the wrong purchase.

Inner Balance does not currently present a low-dose local-only Oestra tier. If dryness and painful sex are your whole list, you would be paying roughly $1,400 more in the modeled first year for a compounded systemic program when an FDA-approved local generic exists for that treatment lane.

If that is your situation, Interlude is the better buy, and we make nothing when you choose it.

Here is the flip side, and it is why Inner Balance exists.

Interlude’s local GSM program is not a whole-body HRT program. If your nights are being wrecked by hot flashes and night sweats, the cheaper local cream is not cheaper—it simply does not do the job you are shopping for. Inner Balance’s Oestra is built around systemic exposure and combines estradiol and progesterone into one compounded product.

But do not let the word “bundle” erase the fine print. Inner Balance’s current price includes the prescription treatment, shipping, and unlimited clinical follow-up, while its pricing page says dose adjustments may carry an additional cost. That needs to be part of the value calculation, not buried after checkout. (Inner Balance menopause pricing)

The damaging admission does not disappear because Inner Balance is our partner: Oestra is the wrong buy for local-only symptoms, the wrong buy for an FDA-approved-only reader, and the wrong buy for anyone unwilling to resolve its current formula and pharmacy conflicts before paying.

Is there an age limit on either one?

Interlude says there is no age limit for its low-dose vaginal estrogen products. Inner Balance publishes a cutoff to start at age 59, even for women already using HRT. That is an Inner Balance policy—not a universal rule that systemic hormone therapy must stop at 59 or 60.

Interlude places “There is no age limit” on its generic cream and insert product pages. (Interlude generic cream; Interlude inserts)

Inner Balance publishes this sentence in an education article rather than on the primary Oestra checkout page: its cutoff to start is age 59, even if a woman has already used HRT for years. The wording does not clearly say whether someone who is exactly 59 qualifies, so confirm that before entering payment details. Age 60 and older is plainly outside the published cutoff. (Inner Balance age policy)

Do not turn that company rule into a medical rule. The Menopause Society says hormone therapy decisions should be individualized and that there is no single mandatory stopping age; the benefit-risk balance depends on symptoms, health history, route, dose, and timing. (The Menopause Society)

Why the age difference still follows the two treatment lanes

The local-versus-systemic distinction explains why the policies look so different. Low-dose vaginal estrogen is used specifically for GSM and has minimal systemic absorption. Systemic therapy has a broader benefit-risk assessment, and most guidance treats age and years since menopause as part of that individual assessment.

The unmet need in older women is not theoretical. A 2025 JAMA Network Open study identified 1,838,732 female Medicare beneficiaries with a GSM-related diagnosis. Only 9.0% filled a vaginal-estrogen prescription, and the median time from diagnosis to the first fill was 15 months. (Gallo et al., 2025)

Nine percent. Fifteen months.

Interlude’s no-age-limit local-treatment lane is commercially important because the women most likely to need GSM treatment are not necessarily the women a systemic subscription chooses to start.

What does Interlude vs Inner Balance cost in year one?

Interlude’s shipped generic cream models to $202–$379 in year one depending on the refill cadence you select. Inner Balance costs $1,791 in year one and $1,194 for a later full year at the published continuing rate. The gap is real, but it is not a verdict because the services do different jobs.

Route	First-year amount	What the number includes
Interlude generic cream, one tube every four months	$202	$45 consult + $39 first tube + two $59 refills
Interlude generic cream, one tube every three months	$261	$45 consult + $39 first tube + three $59 refills
Interlude generic cream, default two-month cadence	$379	$45 consult + $39 first tube + five $59 refills
Interlude prescription transferred to a local pharmacy	$45 + your pharmacy price	Consult plus the pharmacy’s medication charge; insurance or discount pricing may apply
Inner Balance Oestra, first six months	$1,194	$199 × 6
Inner Balance Oestra, year one	$1,791	$199 × 6 + $99.50 × 6
Inner Balance Oestra, later 12-month year	$1,194	$99.50 × 12, assuming the published rate remains unchanged

Interlude assumptions: the current first tube remains $39, later tubes remain at the displayed $59 undiscounted price, the prescription remains valid for the modeled cadence, and the user does not incur expedited shipping or a new review during that first year. The model counts charges from enrollment through the end of month 11; a shipment charged exactly on the first anniversary falls into the next 12-month period. Interlude’s pricing page says most women choose a two-to-four-month cadence and allows a selected frequency. The company’s pages conflict on whether the consultation covers six or seven refills, but either count is enough for the five-refill two-month model shown here. (Interlude pricing; Interlude FAQ; generic cream)

Inner Balance assumptions: the published monthly rate remains $199 for months one through six and $99.50 afterward, with no charge for optional labs, outside prescriptions, or a dose adjustment. Inner Balance says Oestra is supplied in 90-day quantities replenished every 90 days while the subscription is billed monthly. Inner Balance says dose changes may cost extra, so the real total can exceed the base subscription. (Inner Balance menopause pricing)

Why the local-pharmacy total is not fixed

A universal $135 “transfer it to your own pharmacy” total would be a guess. Interlude does permit a prescription transfer to a local pharmacy, but the medication cost depends on the pharmacy, manufacturer, insurance, deductible, discount program, and quantity. The only universal number we can verify for that route is $45 plus the pharmacy’s actual charge. (Interlude FAQ)

Interlude’s year-two cost also cannot be labeled “similar to year one.” Interlude says a renewal review fee may apply after the prescription expires, but it does not publish that renewal fee on the public pricing page. Year two cannot be calculated honestly from the current public materials.

Now the fence, and please do not skip it

This table compares what each company charges. It does not compare like with like, and the smallest number is not automatically the winner.

If your symptoms are whole-body, the $202 row does not solve your problem. If your symptoms are local only, the $1,791 row buys a broader systemic program you may not need. Choose the lane first. Then compare the price inside that lane.

Does the systemic lane sound like your situation, and are you comfortable with a compounded final product? Check Inner Balance’s current eligibility and pricing. Affiliate link: The HRT Index may earn a commission if you enroll. Verify the formula, pharmacy, age rule, and full charge schedule before checkout.

Why does one have progesterone and the other does not?

Because the products sit in different treatment categories. The Menopause Society says a progestogen is not indicated with low-dose vaginal estrogen, although endometrial safety beyond one year has not been studied in trials. Systemic estrogen is different: women with a uterus generally need an appropriate endometrial-protection strategy.

The Menopause Society’s 2020 GSM position statement says that when low-dose vaginal estrogen, vaginal DHEA, or ospemifene is used, a progestogen is not indicated; it also states that endometrial safety has not been studied in clinical trials beyond one year. (2020 GSM position statement)

So Interlude’s local products not containing progesterone is not a missing feature. It fits the local low-dose category.

Oestra contains progesterone because Inner Balance positions it as systemic estradiol-plus-progesterone therapy. For a woman with a uterus using systemic estrogen, progestogen is generally used to protect the endometrium from estrogen stimulation. (The Menopause Society)

The open question we will not answer for you

Including progesterone and establishing that a particular compounded dose and route adequately protect an individual woman’s uterine lining are not the same thing.

That distinction matters more here because Inner Balance currently publishes multiple Oestra dose descriptions:

Current Inner Balance source	Estradiol	Progesterone
Oestra product page	3 mg per pump	100 mg per pump
Help Center: Oestra Menopause	0.5 mg	50 mg
Help Center: Oestra Start	About 2 mg	About 80 mg

Source: Oestra product page and Oestra Menopause vs Oestra Start, rechecked August 18, 2026.

That is too wide a spread for an editorial page to guess which formula a new patient will receive or whether the same amount is used in every state, age group, or symptom pattern.

If you have a uterus, ask this in writing:

“Which exact formula and dose am I being prescribed, what evidence supports the progesterone route and dose for protecting my uterine lining with this estradiol dose, and how will unexpected bleeding be evaluated?”

One firm line applies no matter which provider you are considering: postmenopausal bleeding or persistent unexplained bleeding needs prompt clinical evaluation. FDA-approved estrogen labeling lists unexplained genital bleeding as a contraindication and instructs postmenopausal women to report vaginal bleeding promptly. (DailyMed: Estradiol Vaginal Cream 0.01%)

What if you need both local and whole-body treatment?

Local treatment does not treat hot flashes, and systemic treatment does not always fully resolve vaginal or urinary symptoms. Some women use systemic hormone therapy and low-dose local vaginal estrogen together. Neither Interlude nor Inner Balance, as currently structured, is the obvious one-provider answer for that combined job.

This is where forcing the comparison into an either/or becomes actively unhelpful.

The Menopause Society notes that low-dose vaginal estrogen may be used for persistent GSM even when a woman is already using systemic hormone therapy. (The Menopause Society: Hormone Therapy)

If hot flashes and dryness are both on your list, stitching together two separate subscriptions from companies that do not share a chart can create avoidable confusion around dose, side effects, refills, and who is responsible for follow-up.

A cleaner route is one clinician or coordinated care team that can evaluate the whole symptom pattern and prescribe FDA-approved systemic therapy, local therapy, both, or a nonhormonal option when appropriate.

Both symptom lanes on your list? Use Find My HRT Path to compare providers that can evaluate systemic and local treatment together rather than buying two disconnected subscriptions.

Do Interlude and Inner Balance require labs or video visits?

Neither public pathway requires routine pre-treatment bloodwork for every customer. Interlude uses an online assessment reviewed by an MD or GYN and may follow up by phone, video, or secure chat. Inner Balance says no separate initial appointment is required and that labs are optional, with ongoing clinical follow-up included.

Care step	Interlude	Inner Balance
Entry point	Checkout and online medical assessment	Health quiz and clinical review
Prescription review	Licensed MD or GYN reviews the information	Licensed clinician reviews and approves if appropriate
Mandatory separate video visit	Not stated as mandatory; follow-up may be phone, video, or secure chat	Provider says no separate appointment is required initially
Routine labs before starting	Not listed as a standard requirement for the local products	Provider says labs are optional
Ongoing messaging	Included while the prescription relationship is active	Unlimited clinical follow-up advertised
Medication shipment	Product-dependent refill cadence; generic cream can be set between two and four months	Three-month supply, replenished every 90 days while billing remains monthly
Dose changes	Clinician-directed; product instructions vary	Clinician-directed; may incur an additional cost
Primary-care replacement	No	No

Source: Interlude generic inserts, Interlude FAQ, and Inner Balance HRT page.

The convenience is real. So is the limitation.

Neither asynchronous platform can perform a pelvic examination, culture a urine sample through the screen, image the uterus, biopsy the endometrium, or replace a clinician who coordinates the rest of your health history. A questionnaire-first process is a strength for a straightforward case and a weakness when the diagnosis itself is uncertain.

Can you use insurance, HSA, or FSA with either one?

Neither provider bills insurance for its core service. Both say HSA/FSA cards can be used. Interlude can transfer its prescription to a local pharmacy, where your pharmacy benefit may apply. Inner Balance’s direct-service terms say it does not bill commercial insurance, Medicare, or Medicaid.

Interlude describes itself as cash pay and says it does not accept insurance. Its FAQ says you can ask support to transfer the prescription to a local pharmacy, where the price depends on the pharmacy and insurance coverage. Interlude does not accept transferred prescriptions into its own service. (Interlude FAQ)

Inner Balance’s terms describe a direct cash-pay service that does not bill commercial insurance, Medicare, or Medicaid. The terms also say outside tests, outside prescriptions, or use of another pharmacy can create separate costs. (Inner Balance Terms)

Both providers say Oestra or prescription care may be paid with HSA/FSA funds. But Inner Balance currently contradicts itself on what happens if you later request a refund:

• Its HSA/FSA page says HSA/FSA purchases are nonrefundable and excluded from the six-month guarantee.
• Its refund policy says qualifying HSA/FSA purchases are eligible for a refund.

That is not a wording quibble. If the guarantee matters to you, get the refund rule in writing before paying with an HSA or FSA card. (Inner Balance HSA/FSA; Inner Balance refund policy)

A receipt is also not automatically a superbill. Ask what documentation the provider supplies before assuming an out-of-network claim or reimbursement will work.

Are Interlude and Inner Balance legitimate?

Both operate public prescription telehealth pathways with clinician review and medication fulfillment. That establishes that they are functioning services; it does not prove that either treatment is right for you. The more important trust question is whether each company’s current pages agree on the facts that change your prescription and your bill.

The HRT Index checks a provider in this fixed order:

1. Clinical legitimacy — prescription requirement, clinician review, identifiable medical and pharmacy entities, scope, and escalation limits.
2. Care quality — assessment depth, clinician access, continuity, follow-up, side-effect handling, and record access.
3. Medication fit — local versus systemic, exact formulation, dose, route, and FDA-approved versus compounded status.
4. Price transparency — first charge, first 90 days, first year, refill cadence, extras, cancellation, and refund rules.
5. Access — state, insurance, HSA/FSA, shipping, support, and pharmacy transfer.

A legitimate provider can still be the wrong category, wrong formulation, wrong price, or wrong care model for you.

Which current contradictions matter before you pay?

Interlude’s unresolved issues are primarily commercial:

Interlude source conflict or friction	Why it matters
Product and pricing pages say up to seven refills; the FAQ says six refills or one year	Changes the maximum number of fills, although it does not change the first-year models on this page
Automatic shipments cannot simply be switched off; you must postpone a shipment or cancel all shipments	Creates a recurring-payment task the user must actively manage
The consult fee is nonrefundable, while the medication charge is refunded if no medication is prescribed	The phrase “refund if you do not qualify” does not mean every charge returns
The renewal review fee is not published	Makes year-two cost impossible to calculate from public materials

Inner Balance’s unresolved issues are clinical or materially tied to the medication:

Inner Balance source conflict	Why it matters
Product page says 3 mg estradiol + 100 mg progesterone; Help Center lists 0.5/50 and about 2/80 formulas	Changes the dose a reader thinks she is buying
Product badge says 503A; product FAQ says 503B	Changes the pharmacy framework the provider claims applies
HSA/FSA page excludes those purchases from refunds; refund policy says they can qualify	Changes the practical value of the guarantee
Provider pages have published both 43 states plus D.C. and 50-state access	Means exact availability must be confirmed during intake

Here is the sentence we want you to leave with: Interlude’s unresolved issues can change what you pay. Inner Balance’s unresolved issues can change what you believe is going into your body.

The innocent explanation comes first: public pages get stale, teams update different sections at different times, and product variants evolve. None of that requires bad faith. It does require getting the load-bearing answer in writing before you hand over a card.

What do customer reviews tell you?

Reviews can help with ordering, shipping, communication, and cancellation friction. They cannot establish that a hormone regimen is safe, effective, or appropriate.

Provider	Source	Dated snapshot	How to read it
Interlude	Trustpilot	4.8 from 956 reviews in the current indexed snapshot	Large outside-platform sample; Interlude asks customers to review
Inner Balance	Provider website	4.9/5 from 5,695 reviews	Provider-hosted and provider-controlled presentation
Inner Balance	Trustpilot	3.1 from 15 reviews	Very small outside sample; Trustpilot warns it may not be representative

A current verified Interlude reviewer described the service as: “Super responsive. Very fast shipping. Clear instructions.” A current Inner Balance reviewer wrote that the refund process was “smooth and quick just as the guarantee states.” Those are service observations, not medical evidence. (Interlude Trustpilot; Inner Balance Trustpilot)

We deliberately left out customer claims that a cream cured symptoms, prevented disease, or was “safer.” A review can describe a package or a refund. It cannot establish clinical suitability for someone else.

What does it take to stop paying either one?

Interlude’s current checkout offers an as-needed refill option, contradicting its older FAQ statement that automatic shipments cannot be turned off. For recurring orders, its refund page requires cancellation or rescheduling at least two days before shipment. Inner Balance allows cancellation, but its six-month guarantee requires a separate refund request within two clocks.

Cancellation question	Interlude	Inner Balance
Recurring fulfillment or billing	Optional in the current checkout; recurring one-to-four-month schedules are also available	Yes
Can you avoid automatic refills?	Current checkout offers “I’ll contact you when I need a refill”; older FAQ language conflicts	Subscription can be canceled in the portal
Reminder before charge or shipment	Interlude says it emails and texts before recurring orders	Confirm current reminder timing in the portal
Published cutoff	At least two days before a scheduled shipment	Before the next billing cycle; verify the exact calendar date shown
Does cancellation trigger a refund?	No	No
Medication refunds	No refunds for dispensed prescription medication; defective products have a separate replacement process	Dispensed medication and excluded third-party costs are subject to policy limits
Special guarantee	No comparable broad guarantee identified	Up to six months of qualifying Oestra subscription fees
Refund request deadline	Not applicable to a broad guarantee	Within six months of original order and within 14 days after cancellation
Limit	—	One qualifying refund per customer

Source: Interlude checkout, Interlude FAQ, Interlude refunds, Inner Balance terms, and Inner Balance refund policy.

The current Interlude checkout is more flexible than the older FAQ: a customer can select as-needed fulfillment or choose a recurring cadence. Because both statements remain live, save the selected refill setting and the next shipment date at checkout.

Inner Balance’s guarantee is the more generous headline and the easier one to lose by assuming cancellation is enough. “Cancel anytime” and “receive a refund” are separate actions. You can cancel, feel finished, and miss the refund because the second request never went in within 14 days.

Set a calendar reminder the day you cancel. That is the whole fix.

Your cancellation checklist

• [ ] Screenshot the cancellation confirmation
• [ ] Write down the cancellation date
• [ ] Confirm the next charge date in writing
• [ ] Ask whether anything already shipped will still be billed
• [ ] File the refund request separately when a guarantee requires it
• [ ] Save the refund approval
• [ ] Follow up before the 14-day Inner Balance window closes

When is neither one the right starting point?

Some situations need diagnostic or in-person care before an online hormone subscription. Bleeding after menopause, unexplained bleeding, a new breast change, possible pregnancy, severe pelvic pain, certain cancer histories, a prior clot, stroke or heart attack, or significant liver disease should not be routed through a comparison-page CTA.

We would rather lose the click than route you wrong. Skip both for now and seek appropriate clinical evaluation when any of these applies:

• Vaginal bleeding 12 months or more after your final period
• Unexplained bleeding at any point
• A new breast lump or significant breast change
• Severe or new pelvic pain
• Repeated urinary symptoms that have never been confirmed or properly evaluated
• A history of an estrogen-sensitive cancer or a complex oncology history
• A prior blood clot, stroke, or heart attack
• Significant liver disease
• Any chance you could be pregnant
• Symptoms you cannot confidently attribute to menopause
• A need for a pelvic exam, culture, ultrasound, biopsy, or coordinated specialist care

The FDA lists unexplained vaginal bleeding, certain cancers, prior heart attack or stroke, blood clots, liver disease, and pregnancy among major factors that can make menopausal hormone therapy inappropriate or require specialist assessment. (FDA: Menopause and hormones)

Neither provider is emergency care. If something feels like an emergency, treat it like one.

What did The HRT Index actually verify?

We read the current provider product pages, pricing, FAQs, terms, refund rules, Help Center materials, and primary menopause sources. We calculated the cash-flow models ourselves, preserved unresolved conflicts instead of choosing the convenient version, and did not complete either intake or inspect a shipment.

Verified on current provider pages

• Interlude’s $45 one-time consult, $39 introductory generic-cream price, and $59 displayed undiscounted price.
• Interlude’s 42.5 g generic cream, 0.01% strength, and two-to-three-month supply estimate.
• Interlude’s current $109 introductory insert price and $129 displayed undiscounted price.
• Interlude’s $49 introductory compounded Soothing Estradiol and DHEA cream prices.
• Interlude’s selected refill cadence, free shipping, transfer-out option, cash-pay policy, and auto-shipment controls.
• Interlude’s no-age-limit statement on local-product pages.
• Inner Balance’s $199 monthly first-six-month price and $99.50 continuing rate.
• Inner Balance’s included prescription, shipping, and unlimited clinical follow-up.
• Inner Balance’s statement that labs are optional and dose adjustments may cost extra.
• Inner Balance’s age-59 cutoff statement.
• Inner Balance’s refund deadlines and separate-request requirement.
• The conflicting Oestra dose, pharmacy, HSA/FSA refund, and state-availability descriptions.

Calculated by The HRT Index

• Interlude’s $202, $261, and $379 first-year generic-cream models at four-, three-, and two-month cadences.
• Interlude’s $0.92 versus $1.63 introductory per-gram comparison for generic versus Soothing cream.
• Inner Balance’s $597 first-90-day, $1,194 first-six-month, $1,791 first-year, and $1,194 later-year base subscription totals.
• The approximately $1,412 difference between the $379 Interlude default-cadence model and Inner Balance’s $1,791 first year.

Provider statements we did not adopt as clinical fact

• Inner Balance’s claims of better absorption, more stable levels, fewer side effects, superior safety, or greater effectiveness than approved pills or patches.
• Inner Balance’s internal symptom-improvement percentages.
• Any implication that “bioidentical” means safer, more natural, or FDA-approved.
• Interlude’s product-specific timelines as a guarantee of individual results.
• Any customer testimonial as proof of effectiveness or safety.

Conclusions we deliberately refuse to make

• Which Oestra formula a particular reader will receive.
• Whether a particular compounded progesterone dose provides adequate endometrial protection for an individual woman.
• Whether either treatment will work for you.
• Whether either provider is clinically appropriate for your history.
• Whether Inner Balance’s dispensing pharmacy is operating under section 503A or 503B for your order.

Still unresolved after public-source verification

• Whether Interlude’s consultation covers six or seven refills.
• Interlude’s renewal-review fee after the first prescription period.
• The exact Oestra formula supplied to a new menopause customer.
• Inner Balance’s exact 503A/503B dispensing framework.
• Inner Balance’s exact current state list.
• Whether an HSA/FSA-funded Oestra purchase qualifies for the guarantee.
• The exact price of an Inner Balance dose adjustment.

What we did not do

We did not complete either medical intake, submit payment, test a cancellation, request a refund, inspect a shipment, or verify the label on a dispensed product. We hold no first-party patient reviews and assign no numeric provider score.

How we reached the verdict

This page follows The HRT Index Verification Standard: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule. Providers are assessed on five pillars in this exact order: clinical legitimacy, care quality, medication fit, price transparency, access.

No provider paid for ranking position. Inner Balance’s affiliate relationship did not change the conclusion—including the conclusion that Interlude is the better purchase for local-only symptoms.

So which should you choose?

Choose by your symptom lane, not the price tag. Local vaginal or urinary symptoms point to Interlude. Whole-body symptoms may put Inner Balance on the shortlist if you accept compounded care and resolve its formula questions. FDA-approved systemic therapy, mixed symptoms, postmenopausal bleeding, or insurance billing point somewhere else.

If this is you	Start here
Dryness or painful sex without whole-body symptoms	Interlude — local lane; FDA-approved generic option available
Recurrent UTIs or urinary urgency associated with GSM	Interlude
Age 60+ with local symptoms	Interlude may still serve this lane; confirm individual eligibility
Hot flashes and night sweats; compounded care is acceptable	Consider Inner Balance after resolving dose, pharmacy, and age eligibility
You want one estradiol-plus-progesterone vaginal product	Consider Inner Balance
You want FDA-approved whole-body therapy	Neither — compare providers prescribing approved systemic options
You want insurance-billed care	Neither
You have local and whole-body symptoms	One clinician who can evaluate and coordinate both
You have any bleeding after menopause	Clinical evaluation first
You use Medicare or Medicaid	Neither direct-pay service bills those programs

The six questions to ask before you pay either company

Print this. Take it to the intake. It works on both.

1. Which exact product am I being prescribed? Get the product name, strength, dose, and FDA-approved or compounded status in writing.
2. Which pharmacy will fill it? Ask for the pharmacy name and confirm the manufacturer or compounding status from the final label.
3. If I am not approved, exactly which charges come back to me? Separate consultation, medication, shipping, and third-party charges.
4. I have a uterus—what protects my uterine lining on this regimen, and how will unexpected bleeding be evaluated?
5. Is the exact treatment available in my state, and what is the age rule? Do not accept a general nationwide claim when the product or clinician may vary.
6. What is my cancellation deadline as a calendar date, and what happens to charges or shipments already scheduled?

If a company cannot answer all six clearly before you pay, that is your answer.

If whole-body symptoms are your issue, you understand that Oestra is compounded, the $1,791 first-year base cost fits, and you are willing to verify the formula and pharmacy: check Inner Balance’s current eligibility and pricing. Affiliate link: Inner Balance is a paid partner. That relationship did not change the part of this page that tells local-only and FDA-approved-only readers to choose another path.

Frequently asked questions

Is Interlude better than Inner Balance?

For vaginal and urinary symptoms on their own, Interlude is the better fit: it specializes in that category, offers an FDA-approved generic local option, and has a much lower modeled first-year cost. For whole-body symptoms such as hot flashes, Interlude’s local products are not the answer; Inner Balance may fit only if compounded systemic care is acceptable.

Does Interlude treat hot flashes?

Interlude’s core low-dose vaginal estrogen program is not designed to treat hot flashes. Its terms and product pages focus on vaginal atrophy, GSM, vaginal dryness, painful sex, recurrent UTIs, and urgency. Systemic hormone therapy is the category used for vasomotor symptoms.

Is Oestra FDA-approved?

No. Oestra is a compounded prescription preparation. Estradiol and progesterone also exist in FDA-approved products, but those ingredients do not transfer approval to Oestra’s combined formula, dose, base, or vaginal delivery system.

Is Interlude’s cream FDA-approved?

Interlude’s generic estradiol vaginal cream 0.01% is presented as an FDA-approved generic medication. Its 10 mcg generic estradiol inserts are also presented as FDA-approved. Interlude separately sells compounded Soothing Estradiol and DHEA creams, so confirm the exact product rather than treating the whole company as one FDA category.

How much is Inner Balance per month?

Inner Balance currently publishes $199 per month for the first six months and $99.50 per month afterward. That produces a $1,791 first-year base subscription. “From $99.50” is the continuing rate, not the new-customer entry price.

How much is Interlude per month?

Interlude does not publish a monthly membership for its generic cream. It lists a $45 one-time consultation, $39 for the first tube, and a displayed $59 undiscounted tube price. Depending on a two-to-four-month shipment cadence, the modeled first year is $202–$379.

Does Inner Balance have an age limit?

Inner Balance states that its cutoff to start is age 59, even for women already using HRT. The published sentence does not clearly resolve whether someone who is exactly 59 qualifies, so confirm before checkout. This is a provider policy, not a universal rule that hormone therapy must stop at that age.

Does Interlude have an age limit?

Interlude’s generic cream and insert pages state that there is no age limit. Eligibility still depends on the clinician’s review of the individual history and the appropriateness of the exact product.

Can you use vaginal estrogen and whole-body hormone therapy at the same time?

Some women use systemic hormone therapy and low-dose local vaginal estrogen together because systemic treatment may not fully resolve GSM. One clinician or coordinated care team should review the combined regimen rather than two disconnected subscriptions being assembled without shared oversight.

Do I need progesterone with low-dose vaginal estrogen?

The Menopause Society’s 2020 GSM position statement says a progestogen is not indicated with low-dose vaginal estrogen, vaginal DHEA, or ospemifene, while noting that endometrial safety beyond one year has not been studied in clinical trials. Systemic estrogen is a different category and generally requires an endometrial-protection strategy for women with a uterus.

Does either provider take insurance?

Neither bills insurance for the core service compared here. Interlude can transfer a prescription to a local pharmacy, where pharmacy coverage may apply. Inner Balance’s direct-service terms state that it does not bill commercial insurance, Medicare, or Medicaid.

Can I use HSA or FSA funds?

Both providers say HSA/FSA cards may be used. Inner Balance’s current pages conflict on whether HSA/FSA-funded purchases qualify for its refund guarantee, so get that answer in writing before using those funds when the guarantee matters.

Does Interlude require labs?

Interlude does not list routine laboratory testing as a standard prerequisite for its local vaginal products. A clinician may still decide that testing, examination, or outside evaluation is needed based on the symptoms and history.

Does Inner Balance require labs?

Inner Balance says labs are optional and that treatment can begin after symptom and medical-history review when a clinician approves it. Ask what testing is recommended later, whether it is included, and whether a dose adjustment costs extra.

Can I transfer an Interlude prescription to my local pharmacy?

Yes. Interlude’s FAQ says support can help transfer an Interlude prescription to a local pharmacy. The price then depends on that pharmacy and insurance coverage. Interlude does not accept an existing prescription transferred into its own service.

How do I cancel Interlude?

Choose the as-needed refill option at checkout when available, or manage a recurring schedule through the account. Interlude’s older FAQ says automatic shipments cannot be turned off, while the current checkout offers as-needed fulfillment. For a scheduled shipment, its refund policy says to cancel or reschedule at least two days before shipment.

How does Inner Balance’s six-month guarantee work?

Cancellation does not automatically request the refund. A qualifying request must be submitted within six months of the original order and within 14 days after cancellation. The guarantee is limited to one refund per customer and excludes specified third-party costs.

Are both providers available in all 50 states?

Do not rely on a general nationwide-coverage claim. Interlude’s checkout requires a physician licensed in the patient’s state, and Inner Balance has published conflicting state counts. Confirm availability for the exact treatment during intake before paying.

What if I have bleeding after menopause?

Seek prompt clinical evaluation rather than starting, stopping, or adjusting an online hormone subscription on your own. FDA-approved estrogen labeling instructs postmenopausal women to report vaginal bleeding promptly and requires appropriate evaluation of persistent or recurring unexplained bleeding.

What is the expensive mistake to avoid?

If you take one idea away from this page, make it this one: Inner Balance is not the premium version of Interlude, and Interlude is not a budget substitute for Inner Balance. They solve different problems.

The expensive mistake is not simply overpaying. It is buying carefully, saving money, and finding out three months later that the symptom that sent you searching was never in that treatment’s lane.

You already know your symptoms. You just needed someone to tell you which list they belong on.

Still not sure which HRT program is right for you? Take our free 60-second matching quiz.

Find My HRT Path →

Match your symptoms, age, uterus status, medication preference, insurance situation, and state to the right starting point—and see when online care is not the right first move.

---

The HRT Index is an independent decision resource for online menopause and HRT care. This page is editorial research, is not medical advice, and has not been reviewed by a clinician. FDA-approved and compounded medications are labeled separately throughout. Compounded products are not presented as equivalent to, safer than, or more natural than FDA-approved medication. We earn nothing from Interlude. Inner Balance is a paid partner. Last verified August 2026.